Diamantis I. Tsilimigras, MD, PhD, MS
General Surgery Resident, PGY-3
Ohio State University
Columbus, Ohio, United States
Eric Swei, MD
Ohio State University
Columbus, Ohio, United States
Bhavana Konda, MD
Medical Oncologist
Ohio State University
Columbus, Ohio, United States
Jordan M. Cloyd, MD
Associate Professor
The Ohio State University Wexner Medical Center, Division of Surgical Oncology
Columbus, Ohio, United States
Among 5,529 patients who were treated for colonic NET, 308 (5.6%) underwent ER and 5,221 (94.4%) received SR. Patients who underwent ER were older (median age: 55 vs 50 years, p< 0.001), more likely to be African American (27.3% vs 9.6%, p< 0.001), and had similar Charlson-Deyo score compared to individuals who underwent SR (Charlson score> 2: 2.9% vs 3.7%, p=0.48). Median tumor size was slightly higher among patients who underwent SR versus ER (8 mm, IQR:4-12 vs 5 mm, IQR:3-7, p< 0.001), whereas incomplete resection was more common among individuals who underwent ER vs SR (11.4% vs 2.3%, p< 0.001). The 5- and 10-year OS among patients with colonic NET < 20mm was comparable following ER versus SR (5-year OS:90.9% vs 89.0%; 10-year OS:82.3% vs 77.3% , p=0.061, Figure), an association that remained consistent after adjusting for relevant clinicopathologic characteristics, including tumor size, lymph node status and surgical margins (aHR=0.90, 95%CI 0.89-1.25).
Conclusions: Among patients with colonic NETs < 2 cm, ER was associated with comparable long-term outcomes to SR. An endoscopic approach to small colonic NETs should be considered an acceptable approach, similar to current management of rectal NETs, when feasible.